Developing a core outcome set for COVID-19 prevention interventions: the COS COVID-P study
No abstract
Contributors
Kerry Avery, Rhiannon Macefield, Sarah Gorst, Nicola Harman, Susanna Dodd, Mike Clarke, Paula Williamson, Jane Blazeby, on behalf of the COS COVID-P Study Steering Committee
Publication
Journal: Cochrane Database of Systematic Reviews
Volume: 12
Issue: 1
Pages: 15 - 18
Year: 2020
DOI:
10.1002/14651858.CD202002
Further Study Information
Current Stage:
Completed
Date: July 2020 - August 2020
Funding source(s): This study is supported by National Institute for Health Research (NIHR) Senior Investigator Awards (NF-SI_0513-10025 and NIHR200268), the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol (BRC-1215-20011) and the Royal College of Surgeons of England Bristol Surgical Trials Centre.
Health Area
Disease Category: Infectious disease
Disease Name: Coronavirus
Target Population
Age Range: 0 - 120
Sex: Either
Nature of Intervention: Prevention
Stakeholders Involved
- Clinical experts
- Consumers (patients)
- Guideline developers
- Methodologists
- Patient/ support group representatives
- Regulatory agency representatives
- Researchers
- Statisticians
Study Type
- COS for clinical trials or clinical research
Method(s)
- Literature review
- Semi structured discussion